Diaphorase Coupling Protocols for Red-Shifting Dehydrogenase Assays

Mindy I Davis1, Min Shen1, Anton Simeonov1

  • 1NCATS Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health , Rockville, Maryland.

Insights

Developing novel cancer therapeutics targeting dehydrogenases is crucial. This study presents a robust assay using diaphorase coupling to reduce compound interference, enabling high-throughput screening for this important enzyme class.

Area of Science:

  • Biochemistry
  • Enzymology
  • Drug Discovery

Background:

  • Dehydrogenases are critical targets for cancer therapeutics.
  • NAD(P)H fluorescence overlaps with compound libraries, hindering assays.
  • A red-shifted assay is needed to reduce interference.

Purpose of the Study:

  • To develop miniaturized, robust 1,536-well assays for dehydrogenases.
  • To couple dehydrogenases to diaphorase for reduced compound interference.
  • To provide guidelines for high-throughput screening of dehydrogenases.

Main Methods:

  • Coupling dehydrogenases (WT IDH1, mutant IDH1 R132H) to diaphorase.
  • Utilizing resazurin to resorufin conversion for fluorescence detection.
  • Implementing kinetic and endpoint modes for different dehydrogenase activities.
  • Developing counterassays to detect compound interference.

Main Results:

  • Established robust and miniaturized 1,536-well assays for IDH1 and IDH1 R132H.
  • Demonstrated reduced spectral interference from compound libraries.
  • Validated the coupling technique for both NAD(P)H-producing and consuming dehydrogenases.
  • Developed counterassays for reliable interference detection.

Conclusions:

  • The diaphorase coupling method provides a reliable strategy for high-throughput screening of dehydrogenases.
  • This approach minimizes compound interference, enhancing assay accuracy.
  • The developed protocols serve as a foundation for screening diverse dehydrogenases as cancer drug targets.

Related Concept Videos